Oxygen Extraction and Delivery in Elderly During Major Surgery

June 28, 2022 updated by: Sigridur Kalman, Karolinska Institutet

Exploring New Grounds in Physiology of the Elderly- Oxygen Extraction and Delivery During Anaesthesia and Major Surgery

This clinical observational study investigates perioperative oxygen consumption and delivery in elderly patients undergoing major surgery. The primary objectives are to characterise the perioperative oxygen delivery, consumption and potential markers of oxygen debt. Secondary objective is to estimate the correlation between oxygen delivery/consumption and postoperative outcomes to guide the design of a future trial.

Study Overview

Detailed Description

Background Intra- and postoperative fluid therapy aims to achieve or maintain pre-specified thresholds of oxygen delivery/blood flow which can be accomplished by use of fluids with or without inotropic drugs. The used thresholds of oxygen delivery were suggested over 40 years ago, in considerably younger patients compared to the current patients. Update of the characteristics of perioperative oxygen delivery and consumption is reasonable in modern clinical settings.

Primary outcome:

relative changes of oxygen consumption induced by anaesthesia

Secondary outcomes:

relative changes of oxygen consumption and delivery during surgery and postoperatively, oxygen extraction ratio (measured and estimated), potential markers of oxygen debt frequency of in-hospital postoperative complications, mortality (30 Days)

Population:

Men and women ≥65 years undergoing major/complex surgical procedures, when intra-operative cardiovascular monitoring is justified according to clinical decision.

Intervention: no study related intervention, general anaesthesia and surgery according to clinical routine

Blinding: no blinding

Study size:

Pilot study 1: feasibility assessment of study protocol of intra-operative measurements (n= max 10) Pilot study 2: feasibility assessment of study protocol of postoperative measurements (n= max 10) Main study: 60 subjects (20+´40) Planned analysis of oxygen consumption after 20 monitored subjects

Study duration:

Duration of haemodynamic monitoring 24-36 hours Duration of observation of clinical outcomes: 7-10 days, mortality at 30 days postop.

Investigational events:

monitoring of oxygen consumption and delivery monitoring of postoperative clinical outcomes monitoring of markers of tissue injury

Assessments, Procedures and Schedule of Investigational Events:

Subjects are identified by the operation planning list and assessed for eligibility. The study information will be given verbal during the first hospital visit. Subjects who give written informed consent will be included in the study.

Measurements:

oxygen consumption by indirect calorimetry via face mask (in awake state) and via expiratory extension tube of anaesthesia machine (unconscious state) cardiac output monitoring via arterial line (LiDCO) blood samples: arterial and venous blood gase samples, Troponin-T urine samples: N-gal

Clinical outcomes:

Data collection from medical records on postoperative complications using the POMS (postoperative morbidity survey) screening survey at days 3,7 and 10. Postoperative mortality at day 30.

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Stockholm, Sweden, 141 86
        • Karolinska University Hospital Huddinge

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Men and women ≥65 years undergoing major/complex surgical procedures at the Karolinska University Hospital in Huddinge, Stockholm

Description

Inclusion Criteria:

  1. Men and women aged ≥65 years
  2. Major/complex surgery (BUPA AXA classification of surgical severity)
  3. Central and arterial venous catheterization for hemodynamic monitoring.
  4. Written informed consent
  5. Available research team for the measurements If two subjects are eligible the elder one will be chosen. If there are two subjects eligible of different gender and almost the same age, the subject with a gender that is underrepresented by two or more will be chosen. This is consistent with the purpose of including subjects with as high age as possible without interfering with recruitment.

Exclusion Criteria

  1. Concomitant medication with Lithium (interferes with calibration of the LiDCO monitor)
  2. Weight≤ 40 kg.
  3. Not possible to establish arterial or central venous line.
  4. Planned postoperative care at high-dependency unit (POP/IMA) <12hrs.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
oxygen consumption
Time Frame: prior to and 15 minutes after anaesthesia induction
change of oxygen consumption after anaesthesia induction
prior to and 15 minutes after anaesthesia induction

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
oxygen consumption
Time Frame: perioperatively 0-36hrs
changes of oxygen consumption during surgery and postoperative recovery
perioperatively 0-36hrs
oxygen extraction ratio
Time Frame: perioperatively 0-36hrs
ratio between oxygen consumption and oxygen delivery
perioperatively 0-36hrs
oxygen extraction ratio: estimated and measured
Time Frame: perioperatively 0-36hrs
ratio between oxygen consumption and oxygen delivery estimated from blood gases and measured by indirect calorimetry and cardiac output monitoring
perioperatively 0-36hrs
C(v-a)pCO2/C(a-v)O2
Time Frame: perioperatively 0-36hrs
Ratio: venoarterial pCO2 difference/arterio-venous oxygen content difference
perioperatively 0-36hrs
postoperative complications
Time Frame: postoperative days 3,5 and 10
postoperative complications described by Postoperative Morbidity Survey (8)
postoperative days 3,5 and 10
mortality
Time Frame: postoperative days 30
postoperative mortality
postoperative days 30

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Erzsebet Bartha, MD PhD, Karolinska University Hospital Huddinge, Stockholm, Sweden
  • Principal Investigator: Julia Jakobsson, MD, Karolinska University Hospital Huddinge, Stockholm, Sweden

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 27, 2017

Primary Completion (ACTUAL)

March 23, 2018

Study Completion (ACTUAL)

April 4, 2018

Study Registration Dates

First Submitted

November 22, 2017

First Submitted That Met QC Criteria

November 22, 2017

First Posted (ACTUAL)

November 28, 2017

Study Record Updates

Last Update Posted (ACTUAL)

June 30, 2022

Last Update Submitted That Met QC Criteria

June 28, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • K2017-0373
  • 4-500/2017 (OTHER: Karolinska Institutet)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Complications

Clinical Trials on General anaesthesia and major surgery

Subscribe